One million signatures are being sought to promote psychedelic therapy in Europe

One million signatures are being sought to promote psychedelic therapy in Europe

According to a European Parliament report using 2019 data, 84 million Europeans (1 in 6) suffer from mental health conditions, with half experiencing depression or anxiety in the past 12 months. Since the COVID pandemic, these numbers have worsened, becoming a burden for the continent: mental illness costs are estimated at 4.2% of the EU’s annual GDP, equivalent to €600 billion yearly.

Mental health professionals are overwhelmed with patients and lack tools to meet demand: approximately half of patients don’t respond to current medical treatments for depression, anxiety, or PTSD.

Read more